99 related articles for article (PubMed ID: 16806188)
1. The effects by neuroleptics, antimycotics and antibiotics on disulfide reducing enzymes from the human pathogens Acanthamoeba polyphaga and Naegleria fowleri.
Ondarza RN; Iturbe A; Hernández E
Exp Parasitol; 2007 Jan; 115(1):41-7. PubMed ID: 16806188
[TBL] [Abstract][Full Text] [Related]
2. In vitro antiproliferative effects of neuroleptics, antimycotics and antibiotics on the human pathogens Acanthamoeba polyphaga and Naegleria fowleri.
Ondarza RN; Iturbe A; Hernández E
Arch Med Res; 2006 Aug; 37(6):723-9. PubMed ID: 16824931
[TBL] [Abstract][Full Text] [Related]
3. Naegleria fowleri: a free-living highly pathogenic amoeba contains trypanothione/trypanothione reductase and glutathione/glutathione reductase systems.
Ondarza RN; Hurtado G; Tamayo E; Iturbe A; Hernández E
Exp Parasitol; 2006 Nov; 114(3):141-6. PubMed ID: 16620809
[TBL] [Abstract][Full Text] [Related]
4. Drug targets from human pathogenic amoebas: Entamoeba histolytica, Acanthamoeba polyphaga and Naegleria fowleri.
Ondarza RN
Infect Disord Drug Targets; 2007 Sep; 7(3):266-80. PubMed ID: 17897063
[TBL] [Abstract][Full Text] [Related]
5. Drug effects on drug targets: inhibition of enzymes by neuroleptics, antimycotics, antibiotics and other drugs on human pathogenic amoebas and their anti-proliferative effects.
Ondarza RN
Recent Pat Antiinfect Drug Discov; 2007 Nov; 2(3):206-16. PubMed ID: 18221178
[TBL] [Abstract][Full Text] [Related]
6. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
Schuster FL; Guglielmo BJ; Visvesvara GS
J Eukaryot Microbiol; 2006; 53(2):121-6. PubMed ID: 16579814
[TBL] [Abstract][Full Text] [Related]
7. Opportunistic amoebae: challenges in prophylaxis and treatment.
Schuster FL; Visvesvara GS
Drug Resist Updat; 2004 Feb; 7(1):41-51. PubMed ID: 15072770
[TBL] [Abstract][Full Text] [Related]
8. Amoebicidal effect of chlorine dioxide gas against pathogenic Naegleria fowleri and Acanthamoeba polyphaga.
Sohn HJ; Park AY; Lee JH; Yun KH; Song KJ; Kim JH; Shin HJ
Parasitol Res; 2024 Apr; 123(4):192. PubMed ID: 38652173
[TBL] [Abstract][Full Text] [Related]
9. Activities of therapeutic agents against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
Goswick SM; Brenner GM
J Parasitol; 2003 Aug; 89(4):837-42. PubMed ID: 14533700
[TBL] [Abstract][Full Text] [Related]
10. Chinifur, a selective inhibitor and "subversive substrate" for Trypanosoma congolense trypanothione reductase.
Cenas N; Bironaite D; Dickancaite E; Anusevicius Z; Sarlauskas J; Blanchard JS
Biochem Biophys Res Commun; 1994 Oct; 204(1):224-9. PubMed ID: 7945363
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea.
Visvesvara GS; Moura H; Schuster FL
FEMS Immunol Med Microbiol; 2007 Jun; 50(1):1-26. PubMed ID: 17428307
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of Naegleria fowleri from Acanthamoeba species by using monoclonal antibodies and flow cytometry.
Flores BM; Garcia CA; Stamm WE; Torian BE
J Clin Microbiol; 1990 Sep; 28(9):1999-2005. PubMed ID: 2229384
[TBL] [Abstract][Full Text] [Related]
13. Viability of pathogenic Acanthamoeba and Naegleria and virulence of N. fowleri during long-term cryopreservation.
John DT; John RA
Folia Parasitol (Praha); 1996; 43(1):43-6. PubMed ID: 8682409
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of rokitamycin in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
Kim JH; Lee YJ; Sohn HJ; Song KJ; Kwon D; Kwon MH; Im KI; Shin HJ
Int J Antimicrob Agents; 2008 Nov; 32(5):411-7. PubMed ID: 18762406
[TBL] [Abstract][Full Text] [Related]
15. In vitro effect of artesunate against Acanthamoeba spp.
Nacapunchai D; Phadungkul K; Kaewcharus S
Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 3():49-52. PubMed ID: 12971474
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of pathogenic Naegleria and Acanthamoeba speicies to a variety of therapeutic agents.
Duma RJ; Finley R
Antimicrob Agents Chemother; 1976 Aug; 10(2):370-6. PubMed ID: 984777
[TBL] [Abstract][Full Text] [Related]
17. Privileged structure-guided synthesis of quinazoline derivatives as inhibitors of trypanothione reductase.
Cavalli A; Lizzi F; Bongarzone S; Brun R; Luise Krauth-Siegel R; Bolognesi ML
Bioorg Med Chem Lett; 2009 Jun; 19(11):3031-5. PubMed ID: 19414258
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of effective treatment drugs against Acanthamoeba cyst].
Tahara K; Asari S; Shimomura Y; Endo T; Yanagihara T
Kansenshogaku Zasshi; 1997 Oct; 71(10):1025-30. PubMed ID: 9394554
[TBL] [Abstract][Full Text] [Related]
19. Effect of synthetic antimicrobial peptides on Naegleria fowleri trophozoites.
Tiewcharoen S; Phurttikul W; Rabablert J; Auewarakul P; Roytrakul S; Chetanachan P; Atithep T; Junnu V
Southeast Asian J Trop Med Public Health; 2014 May; 45(3):537-46. PubMed ID: 24974637
[TBL] [Abstract][Full Text] [Related]
20. ANTI-AMEBIC ACTIVITY OF DIOSGENIN ON NAEGLERIA FOWLERI TROPHOZOITES.
Rabablert J; Tiewcharoen S; Auewarakul P; Atithep T; Lumlerdkij N; Vejaratpimol R; Junnu V
Southeast Asian J Trop Med Public Health; 2015 Sep; 46(5):827-34. PubMed ID: 26863853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
